| Financial Year |
March 31 2023 |
| Monetary Funds |
3,560,367,710.64 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
466,541,088.03 |
| Advances to Suppliers |
91,167,808.49 |
| Other Receivables |
473,083.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
389,512,314.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
70,234,193.59 |
| Total Current Assets |
4,935,602,570.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
943,012,018.35 |
| Investment Properties |
-- |
| Fixed Assetes |
1,567,326,986.52 |
| Under-construction Projects |
3,241,951,027.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
275,668,551.18 |
| R&D expenses |
10,501,149.55 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,857,622.21 |
| Deferred Income Tax Assets |
19,488,725.65 |
| Other Non-Current Assets |
132,006,613.02 |
| Sub-Total of Non-Current Assets |
6,790,870,319.11 |
| Total Assets |
11,726,472,889.61 |
| Short-Term Loans |
250,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
899,596,064.20 |
| Accounts Received In Advance |
76,975.58 |
| Employee Compensation Payable |
68,024,511.64 |
| Taxes Payable |
49,002,675.96 |
| Interest Payable |
4,205,820.80 |
| Dividend Payable |
2,724,553.75 |
| Other payables |
375,083,626.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,802,300.83 |
| Other Current Liabilities |
23,213,688.63 |
| Sub-Total of Current Liabilities |
1,771,307,397.95 |
| Long-term Loans |
1,291,920,703.31 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
38,447,335.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,469,000,551.72 |
| Total Liabilities |
3,240,307,949.67 |
| Paid-In Capital(Or Share Stock) |
1,156,399,976.00 |
| Capital Surplus |
1,673,365,203.42 |
| Surplus Reserve |
580,341,622.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,482,781,936.01 |
| Minority Stockholder's Interest |
510,110,244.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,976,054,695.03 |
| Owner's Equity（Stockholder's Equity） |
8,486,164,939.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,726,472,889.61 |
